| Literature DB >> 30773345 |
Florentia Kaguelidou1, Geneviève Durrieu2, Antonio Clavenna3.
Abstract
New regulations have come into force in Europe and the US establishing the pediatric development as an integral part of the early development of medicinal products. Parallel to the advances in pediatric clinical research, it became obvious that all available sources and research tools to gather valuable information for the safe and efficacious prescription of medicines in children should be used. Real-life, pharmacoepidemiological studies provide information that contribute to the better knowledge of drug utilization, effects and safety in the pediatric population and thereby, a better prescribing in children. In this paper, we suggest some possible applications, provide examples of impact of pharmacoepidemiological and pharmacovigilance studies and expose future perspectives in pediatric pharmacoepidemiology.Entities:
Keywords: Challenges; Drug development; Pediatrics; Pharmacoepidemiology
Mesh:
Year: 2019 PMID: 30773345 DOI: 10.1016/j.therap.2018.09.077
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070